Introduction
============

*Pseudomonas* is a genetically and metabolically diverse genus of bacteria, which inhabit a wide variety of environments and can act as pathogens of humans, animals and plants. Among the wide variety of *Pseudomonas* species, only few have been recognized as human pathogens, with *Pseudomonas aeruginosa* being the most common cause of infections ([@B17]; [@B29]; [@B44]).

The acquisition by pathogenic *Pseudomonas* species of β-lactamases able to degrade most anti-*pseudomonas* β-lactams and resistant to currently available β-lactamase inhibitors, such as the metallo-β-lactamases (MBLs), can provide a remarkable contribution to the emergence of strains with difficult-to-treat resistance (DTR) phenotypes ([@B27]). VIM-type enzymes are among the most widespread and prevalent acquired MBLs in *P. aeruginosa* ([@B30]), and have occasionally been reported also in other *Pseudomonas* spp. of clinical interest including *Pseudomonas putida, Pseudomonas mosselii, Pseudomonas monteilii, Pseudomonas stutzeri*, and *Pseudomonas mendocina* ([@B58]; [@B37]; [@B22]; [@B40]; [@B1]).

Metallo-β-lactamase genes, and in particular *bla*~V\ IM~- and *bla*~IMP~-type genes, are typically carried on mobile gene cassettes inserted into integron platforms ([@B43]). While among *Enterobacterales* MBL-encoding integrons are mostly associated with plasmid lineages of IncN-, IncI1- and IncHI2-type replicons ([@B10]; [@B56]), less is known about the genetic support of these elements among *Pseudomonas* spp. In these species, MBL-encoding integrons have been described both as chromosomal- ([@B33]; [@B45]; [@B15]; [@B46]) and plasmid-borne, but only few plasmids have been completely sequenced ([@B34]; [@B6]; [@B55]; [@B48]; [@B7], [@B8]; [@B43]; [@B35]), and information about prevalence and diversity of MBL-carrying plasmid lineages remains largely unknown.

In this study we have investigated the genetic support of the *bla*~V\ IM-1~ gene from a non-*aeruginosa Pseudomonas* strains of clinical origin, namely *Pseudomonas mosselii* AM/94, which represents the earliest known VIM-1-producing strain ([@B22]). In that strain, *bla*~V\ IM-1~ was previously shown to be carried on a gene cassette inserted into integron In70, but its genetic support was not further investigated. Here we report that in this strain the integron was plasmid-borne and describe the structure of the *bla*~V\ IM-1~-carrying plasmid from AM/94, named pMOS94. The results of a comparative genetic analysis with pMOS94, allowed the definition of a novel plasmid lineage involved in dissemination of MBL genes among *Pseudomonas* spp.

Materials and Methods {#s1}
=====================

Bacterial Strains and Antimicrobial Susceptibility Testing
----------------------------------------------------------

*Pseudomonas mosselii* AM/94 was isolated in 1994 from the lower respiratory tract of an inpatient in Genoa, Italy ([@B22]). *P. aeruginosa* C/53 and C/57 were isolated in 2014 from bloodstream infections from intensive care patients from Milan, Italy, and the complete genome has been previously determined ([@B21]). Identification to the species level and Sequence Type (ST) of C/57 strain were carried out in silico on whole genome sequence data. Antimicrobial susceptibility testing was carried out by reference broth-microdilution method and results were interpreted according to EUCAST clinical breakpoints (EUCAST breakpoint tables version 9, 2019^[1](#fn01){ref-type="fn"}^).

Plasmid Transfer and Typing
---------------------------

Electrotransformation experiments were performed with electrocompetent *E. coli* DH10B and *P. aeruginosa* PAO-1 using plasmid DNA preparations, obtained as described previously ([@B16]). The broad-host range vector plasmid pME6001 ([@B5]) was used as positive control in electrotransformation experiments. Transformants were selected on LB agar containing ceftazidime (10 mg/L for *E. coli* and 20 mg/L for *P. aeruginosa*) or gentamicin (30 mg/L) for the pME6001 vector. Conjugation experiments were performed in solid medium as previously described ([@B16]), using *E. coli* J53 Azi^R^ as the recipient strain. Ceftazidime (10 mg/L) was used for the selection of transconjugants and sodium azide (150 mg/L) for counterselection of the donor. Plasmid incompatibility groups were determined following the previously described PCR-based replicon typing (PBRT) schemes ([@B11]; [@B18]; [@B57]; [@B32]). In silico typing using plasmid relaxases (MOB) regions ([@B20]) and the mating pair formation (MPF) apparatus ([@B51]) was performed according to the previously proposed classification scheme ([@B25]; [@B41]).

DNA Sequencing and Bioinformatic Analysis
-----------------------------------------

Genomic DNA was extracted as previously described ([@B31]). Plasmid DNA was extracted using Wizard^®^ Plus SV Minipreps DNA purification system (Promega, Madison, United States) according to manufacturer's instructions. Plasmid DNAs from strain AM/94 was subjected to complete sequencing with the Illumina MiSeq platform (Illumina Inc., San Diego, United States) with a 2 × 250 or 2 × 300 bp paired-end approach. A total of 171,952 high quality reads were generated and assembled using SPAdes 3.11 ([@B4]). Sequence annotation was performed using the RAST web-server ([@B3]). Finishing of pMOS94 and pAER57 plasmid sequences was achieved through Sanger sequencing of PCR products spanning contigs' gaps. Sequence comparisons were performed using BLAST^[2](#fn02){ref-type="fn"}^ and Mauve^[3](#fn03){ref-type="fn"}^ Core genome alignments were performed using Roary, using the non-paralog splitting method ([@B42]; [@B47]). Plasmid circular and linear maps were generated using the CGView Server and EasyFig tools, respectively ([@B23]; [@B52]). Comparator plasmid sequences were selected from the NCBI-NIH database (non-redundant) to include all circular molecules with 100% sequence identity at nucleotide level of the *repA-oriV* region of plasmid pMOS94. A tentative plasmid classification based on replicase (*rep*) homology was inferred through nucleotide sequence alignments of *rep* genes from representative members of the IncN ([@B19]), IncW ([@B54]; [@B2]), and IncP9 replicons ([@B49]), collectively clustering into the MOB~F11~ relaxase family, to which pMOS94-like plasmids belong. Plasmids used in this analysis are reported in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}. Sequences were aligned using the MAFFT v.7 server^[4](#fn04){ref-type="fn"}^ with the G-INS-1 progressive method, and the *rep* phylogeny was inferred using the Neighbor-joining method implemented by MAFFT. Phylogenetic trees were visualized and annotated through the Evolview software ([@B28]).

Results
=======

Mapping of *bla*~V\ IM-1~ in a Plasmid From *P. mosselii* AM/94
---------------------------------------------------------------

*Pseudomonas mosselii* AM/94 was previously shown to carry the *bla*~V\ IM-1~ gene cassette as part of an In70 integron platform (5′CS -- *bla*~V\ IM-1~ -- *aacA4* -- *aphA15* -- *aadA15* -- 3′CS) ([@B22]).

To investigate the genetic support of the *bla*~V\ IM-1~ cassette and of its cognate integron in *P. mosselii* AM/94, an S1 nuclease assay and hybridization with a *bla*~V\ IM~-specific probe were performed. Results mapped *bla*~V\ IM~ to a 50 kb plasmid (data not shown), hereafter referred to as pMOS94.

Gene transfer experiments failed in yielding transconjugants using *E. coli* J53 as recipient in conjugation experiments, and transformants using *E. coli* DH10B and *P. aeruginosa* PAO-1 as recipients in electrotransformation experiments.

The PBRT assay ([@B11]; [@B18]; [@B57]; [@B32]), performed on total DNA purified from AM/94, could not identify any plasmid replicon.

Sequence Analysis of pMOS94: General Features and Plasmid Backbone
------------------------------------------------------------------

In order to determine the genetic features of pMOS94, plasmid DNA was purified from AM/94 and completely sequenced. *De novo* sequence assembly yielded a single contig of 51,660 kb in length, which resulted in a 52,002 kb circular molecule, with a raw coverage of 380× and a mean G+C content of 59.6%, following sequence completion.

A total of 71 coding sequences (CDS) were identified by the RAST annotation pipeline, of which 37 had a predicted function consisting in: replication and stability (*n* = 7), transfer (*n* = 14), mobile genetic elements (*n* = 9) and antibiotic resistance (*n* = 7) ([Figure 1](#F1){ref-type="fig"}).

![Circular map of plasmid pMOS94. The circles, from the outermost to the innermost, show: (i) coding DNA sequences (CDSs) encoded on the plus and minus DNA strands (annotation is reported for known genes only); and (ii) the G+C content, shown as deviation from the average G+C content of the entire molecule. Genes encoding proteins of known functions are in different colors, as detailed in the legend.](fmicb-10-01504-g001){#F1}

Plasmid pMOS94 showed a modular organization associated with the following functions: (i) plasmid replication; (ii) conjugal transfer; (iii) antibiotic resistance.

The replication module included genes essential for plasmid replication (*repA, res*) and stability (*stbABC*), as well as a type II toxin-antitoxin system (*vapBC*) for stable maintenance. A putative replication origin (*oriV*) was identified immediately adjacent to *repA*, characterized by four 19-bp (TTCGTCACTCCAGGGACCG) and seven 9-bp (TTCGTCACT) iteron repeats, suggesting a theta-type replication mechanism for pMOS94 ([@B12]).

The transfer module comprised a *trw*-type gene cluster encoding a T4SS machinery, composed by three structurally different components within the same segmented operon ([@B36]) encoding: (i) the inner membrane complex (TrwMKIGB); (ii) the outer membrane core complex (TrwNHFE); (iii) the external pilus (TrwLJ). *In silico* analyses according to the MOB and MPF typing schemes, exploiting T4SS components for classification ([@B20]; [@B51]; [@B25]; [@B41]), revealed that pMOS94 was classifiable either in the MOB~F11~ or in the MPF~T~ families.

The resistance region was organized in two non-contiguous segments, of which one was represented by the In70 integron platform carried on a defective Tn*402*-like transposon, whereas the second included Tn*5393c*, a Tn*3*-family transposon carrying the *strA--strB* genes, coding for phosphotransferases able to confer high level resistance to streptomycin ([@B13]; [@B53]). These segments were located downstream of and within the transfer module, respectively. The interruption of the *trw* operon by insertion of Tn*5393c*, apparently related with a transposition event generating 5-bp direct repeats (DRs) (5′-GAATA-3′) flanking the element, could explain the unability of pMOS94 for conjugational transfer. Conversely, the Tn*402*-like transposon carrying In70 was inserted downstream of the transfer module and upstream of the locus coding for a DNA invertase, a core component of the plasmid backbone associated with replication and stability functions.

Identification and Comparative Analysis of pMOS94-Like Plasmids From Other *Pseudomonas* Strains
------------------------------------------------------------------------------------------------

In order to identify relatives of pMOS94 and to evaluate the possible host range and dissemination of a similar plasmid lineage, and its role in spreading clinically relevant antibiotic resistance determinants, an BLAST screening using the *repA-oriV* region was performed against publicly available databases in NCBI (non-redundant and wgs) (last accessed on April 2, 2019).

Altogether, seven records were identified showing 100% identity with the *repA-oriV* region, of which five were circular plasmids ranging in size from 24 to 80 kb, while two corresponded to putative plasmid sequences from a recently characterized collection of MBL-producing *P. aeruginosa* from Italy ([@B21]). Strains harboring the latter putative plasmids, namely *P. aeruginosa* C/53 and C/57, were available for further analysis, and gaps closure by PCR resulted in two circular elements showing a size of 102 kb. Since C/53 and C/57 were isolated from the same surveillance center in the same period (2014), and showed the same clonality (ST 532) and resistome (data not shown), C/57 was selected as representative for plasmid closure.

Interestingly, the analyzed plasmids were uniquely detected within members of the *Pseudomonas* genus, including strains of *P. aeruginosa, P. putida, and P. mosselii*. All of them carried an MBL-encoding gene (i.e., *bla*~V\ IM~, *bla*~IMP~, or *bla*~BIM~) in association with additional antibiotic resistance determinants ([Table 1](#T1){ref-type="table"}). In most of cases (6/7) the *Pseudomonas* strains were from clinical sources, with the exception of *P. putida* IEC33019, which was from an environmental source. Overall these strains were from five different countries, belonging to two continents, and had been isolated over a prolonged time period spanning over 20-years ([Table 1](#T1){ref-type="table"}).

###### 

General features of the *Pseudomonas* spp. strains and plasmids included in this study.

  Organism (strain)        Isolation year   Geographical region   Plasmid     Resistance determinants^a^                                                            References              Acc. No.
  ------------------------ ---------------- --------------------- ----------- ------------------------------------------------------------------------------------- ----------------------- ----------
  *P. mosselii* (AM/94)    1994             Italy, Genoa          pMOS94      *bla*~V\ IM-1~, *aacA4, aadA1, aphA15, strA, strB, sul1*                              This study and [@B22]   MK671725
  *P. putida* (HB3267)     2004             France, Besançon      pPC9        *aadB, strA, strB, aphA15, aadA1, aacA4, bla*~V\ IM-1~, *cmlA1, sul1, sul2, tet*(A)   [@B39]                  CP003739
  *P. aeruginosa*          2004             Portugal              pCB58       *bla*~V\ IM-2~, *aacA7, aacC1, aacA4v, strA, strB*                                    [@B8]                   KY630469
  *P. aeruginosa*          2007             Spain, Madrid         pAMBL2      *bla*~V\ IM-1~, *aacA4, bla*~V\ IM-1~, *bla*~V\ IM-1~, *aadA1, sul1*                  [@B48]                  KP873171
  *P. putida* (12917)      2012             France                pTROUS2     *bla*~IMP-63,~ *bla*~OXA-19,~ *aacA4v*                                                [@B35]                  MK047611
  *P. aeruginosa* (C/57)   2014             Italy, Milan          pAER57      *aacA4, bla*~V\ IM-1~, *aacA4, aadA1, sul1*                                           This study and [@B21]   MK671726
  *P. putida* (IEC33019)   --               Brazil                pIEC33019   *qnrVC1, bla*~BIM~, *ΔaadA6v, sul1*                                                   --                      CP016446

a

Uncharacterized gene variants are named according to the closest homolog plus "v".

Sequence analysis and comparison of pMOS94 with the other plasmids revealed an overall conserved backbone structure, containing genes involved in stability, maintenance and, in some cases, encoding the T4SS or parts thereof ([Figure 2](#F2){ref-type="fig"}). Except for pAMBL2, where the transfer operon and the cognate relaxase were fully lacking, all plasmids were found to belong to the MOB~F11~/MPF~T~ families and were untypeable by the replicon typing scheme, as pMOS94.

![Linear map of VIM-1 encoding plasmids from different *Pseudomonas* spp. Year (when available), geographical region and species of isolation are indicated. Homologous segments are indicated by striped shading, representing 75--99% and ≥99% sequence identity. Genes encoding proteins of known functions are in different colors, as detailed in the legend.](fmicb-10-01504-g002){#F2}

Compared to pMOS94, pIEC33019 exhibited the closest conserved architecture, with major differences due to the acquisition of mobile genetic elements targeting a different backbone region ([Figure 2](#F2){ref-type="fig"}). Conversely, the most diverging elements were pAMBL2, pPC9 and pAER57. Plasmid pAMBL2 was a small (24.1 kb) deletion derivative of pMOS94, where the entire *trw* locus was lacking, carrying only genes essential for replication processes and a multiresistance region ([Figure 2](#F2){ref-type="fig"}; [@B48]). Plasmid pPC9 was characterized by a mosaic architecture, carrying mobile genetic elements and multiple genes coding for metal (e.g., *merEA*) and antibiotic resistance (e.g., In860) ([Figure 2](#F2){ref-type="fig"} and [Table 1](#T1){ref-type="table"}; [@B39]). Plasmid pAER57 was the largest identified element of this lineage (\>100 kb), and was characterized by a more complex chimeric arrangement, including a 43 kb segment sharing 87% nucleotide identity with the archetypal IncP-9 pWW0 catabolic plasmid from *P. putida* (GenBank Acc. No. AJ344068) ([@B24]; [@B49]). The 43 kb segment, likely acquired through recombination with a pWW0-like plasmid, included genes coding for replication (e.g., *res-oriV-rep*), partitioning (e.g., *parABC, korA*), transfer (e.g., *mpfABCDEFGHIJ*) and unknown functions. Therefore, pAER57 was classifiable as a multi-replicon plasmid, being characterized by an additional replication locus (i.e., *res-oriV-rep*) 91% identical to that of pWW0.

Analysis of SNPs evaluated on core orthologous genes of pMOS94-like plasmids showed an overall limited sequence diversity. In detail, all plasmids differed only by 1--2 SNPs from each other, with the exception of pAER57 that was the more divergent, showing 13--14 SNPs differences.

Further sequence analysis revealed that members of this plasmid lineage were also able to integrate into the host chromosome as linear elements. Evidences of integration came from a recent study reporting on the structure of a chromosomal genomic island carrying an MBL determinant from a *P. aeruginosa* strain of clinical origin isolated in Prague in 2015 (GenBank acc. no. KY860572). In this case, the integrated element was apparently a deletion-derivative of pMOS94 (carrying only backbone essential regions coding for replication functions) inserted within a Tn*2* family transposon (Tn*6162*), in turn embedded into a genomic island (PACS171b) previously described in high risk clones of *P. aeruginosa* (i.e., ST 235) as chromosomal support of MBL-encoding genes ([@B38]; [@B15]).

Noteworthy, a plasmid lineage closely related (84--87% identity of the *repA-oriV* locus and belonging to the MOB~F11~ and MPF~T~ families) to the one identified in this study was detected in the NCBI non-redundant database and included elements preferentially circulating within the genus *Pseudomonas*. These elements included: (i) plasmid pCT14 encoding mercury resistance from *Pseudomonas veronii* ([@B9]); (ii) two unnamed plasmids from *P. aeruginosa* AR_0356 and 163940 producing a KPC-2 carbapenemase (GenBank acc. nos. CP027168.1 and CP029092.1); (iii) plasmid pTROUS1 from *P. aeruginosa* 163940 producing an IMP-63 carbapenemase (GenBank acc. no MK047610.1), and (iv) a non-circular molecule resembling a plasmid element (GenBank acc. no. LC350084.1) coding for a VIM-2 carbapenemase. Notably, most of these elements were associated with clinically relevant resistance determinants and, according to available metadata, were of clinical (pTROUS1 and LC350084.1) or environmental (pCT14) origin. Using the *repA-oriV* locus as probe, at least 96 records were found among *Pseudomonas* spp. draft genome sequences in NCBI wgs database (i.e., showing 100--90% identity), highlighting a potential wide dissemination of pMOS94-related elements. Nevertheless, the plasmidic nature of such records could not be verified due to their fragmentation and unfinished status. In order to infer possible phylogenetic relationships between pMOS94, pMOS94-related plasmids (i.e., those showing 84--87% identity of the *repA-oriV* locus) and known plasmid replicons belonging to the MOB~F1~relaxase family, to which pMOS94-like plasmids belong, a classification according to the *rep* locus was attempted. The analysis showed that pMOS94 and related plasmids clustered in a separate branch, that appeared more closely related to IncW than IncN and IncP9 replicons ([Figure 3](#F3){ref-type="fig"}).

![Neighbor-joining phylogenesis of replicase encoding genes (*rep*) from representative members of the IncN-, IncW-, and IncP9-type replicons, collectively clustering within the MOB~F11~ relaxase family. Selected plasmids and the corresponding host bacterial species are reported in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}. IncP9 plasmid subgroups are indicated with Greek letters. ^∗^Plasmid pMOS94 was selected as representative of pMOS94-like plasmids, showing 100% identity with the *repA-oriV* region.](fmicb-10-01504-g003){#F3}

Genetic Environment of the MBL-Encoding Genes in the pMOS94-Like Plasmids
-------------------------------------------------------------------------

All seven plasmids of the pMOS94-like lineage described above carried an MBL-encoding gene, embedded in a class I integron platform ([Figure 4](#F4){ref-type="fig"}), including *bla*~V\ IM-1~ in four plasmids, and the *bla*~V\ IM-2~, *bla*~BIM~, and *bla*~IMP-63~ in the remining ones. The *bla*~V\ IM-1~ gene was found embedded in the In70 integron (in pMOS94) or in its derivatives (e.g., In110, In860, In1167) carrying a modified version of the typical gene cassette array of this element (i.e., in pAMBL2, pAER57, and pPC9). On the other hand, the other MBL genes were carried in integrons of different structure (e.g., In58, In1326, and In1297; [Figure 4](#F4){ref-type="fig"}). Despite their heterogeneity, the MBL-encoding integrons always carried aminoglycosides resistance determinants, with *aacA4* variants being the most frequent ([Figure 4](#F4){ref-type="fig"}). Most of the integrons carried typical 5′CS and 3′CS regions, except for In110 in pAER57, where the *intI1* gene was partially deleted ([Figure 4](#F4){ref-type="fig"}).

![Structure of the cassette arrays and of the genetic context of MBL-harboring class 1 integrons carried on the analyzed plasmid. Integron name, year (when available), geographical region and species of isolation are indicated. MBL encoding gene cassettes are indicated by red arrows; gene cassettes encoding for other resistance enzymes (e.g., aminoglycosides and phenicols) are indicated by white arrows; *intI1* integrase gene and 3′-conserved segments (3′CS) flanking the cassette array are indicated by black arrows; *tni* defective module is indicated by light gray arrows; genes flanking the Tn*402*-like insertion points (including *repA* gene and genes encoding for DNA invertase and resolvases) are indicated by dark gray arrows; hypothetical proteins are indicated by striped arrows. IS*Pa17* is shown as light blue boxed arrows bounded by light blue vertical bars. Other ISs and mobile elements are shown as yellow boxed arrows. Tn*402*-like transposon 25-bp IRs are indicated by a black vertical line. When present, DRs flanking the different mobile elements are shown as black dots. The diverse insertion point of Tn*402*-like transposons in pTROUS2 and pCB58 is indicated by an asterisk. Homologous segments (\>99%) generated by a BLASTn comparison are shown as gray striped blocks that are connected across the different structures.](fmicb-10-01504-g004){#F4}

The MBL-encoding integrons were always associated with defective Tn*402*-like transposons. In most cases (namely pAMBL2, pPC9, pMOS94, pAER57, and pCB58), the Tn*402* 25 bp inverted repeats (IRi and IRt) were present at the boundaries of the defective transposons, while in the remaining plasmids (i.e., pTROUS2 and pIEC33019) IRi was present adjacent to the integrase gene, suggesting recombination events which deleted the IRt end. The Tn*402 tni* transposition module was present downstream the 3′CS region in a partially deleted form (in five plasmids), or completely absent (in the others) ([Figure 4](#F4){ref-type="fig"}).

In some cases, additional mobile elements were found within the Tn*402* elements, targeting the cassette array or other regions ([Figure 4](#F4){ref-type="fig"}). The IS*Psp7*-like and IS*110*-like insertion sequences, respectively targeting the cassette arrays of pTROUS2 and pIEC33019 were flanked by DRs, suggesting acquisition by transposition.

Evolutionary History of the Tn*402*-Like Transposons Carried by pMOS94-Like Plasmids
------------------------------------------------------------------------------------

In all cases the Tn*402*-like elements carried by the pMOS94-like plasmids were not flanked by 5 bp DRs, that represent the molecular markers of the transposition of this kind of mobile elements, suggesting that acquisition had involved different recombination events, or that recombination events involving one transposon moiety had occurred after transposition.

In all plasmids but pIEC33019, the Tn*402*-like element was inserted into an A-T rich region located upstream of the locus coding for a DNA invertase. Within this region, all the Tn*402*-like elements carrying *bla*~V\ IM-1~ were inserted at the same site (i.e., 258 bp upstream of the DNA invertase gene), while the remaining ones were inserted slightly upstream (i.e., 281 bp upstream of the DNA invertase gene). On the other hand, in plasmid pIEC33019 the Tn*402*-like element was inserted in a different backbone region located downstream of *repA* ([Figure 4](#F4){ref-type="fig"}).

Interestingly, all Tn*402*-like transposons carrying *bla*~V\ IM-1~ were flanked by a copy of the IS*Pa17* insertion sequence ([@B26]), located upstream of the IRi end ([Figure 4](#F4){ref-type="fig"}). Conversely, a different IS*Pa17*/Tn*402*-like transposon assembly was found in plasmid pTROUS2, where the IS element was inserted downstream of the class I integron 3′CS region and disrupted the *tniA* gene ([Figure 4](#F4){ref-type="fig"}). This IS was already described as associated to MBL-encoding Tn*402*-like transposons aboard plasmids from GNNFs, where it likely contributed to the MBL gene platform acquisition through a novel transposition mechanism exploiting the similarity between the Tn*402* IRs and their counterparts in IS*Pa17* ([@B14]; [@B7]; [@B35]). Nevertheless, in pMOS94-like plasmids no evidence of an IS*Pa17*-mediated mobilization was found, since no DRs bounding the IS*Pa17* IR-L and the Tn*402* IRt end were detected ([Figure 4](#F4){ref-type="fig"}).

Discussion
==========

In this work we characterized the *bla*~V\ IM-1~-carrying plasmid pMOS94 from *P. mosselii* AM/94 isolated in Italy in 1994, which represents the earliest known VIM-producing strain ([@B22]). Analysis of the complete sequence of pMOS94 led to the identification of a novel plasmid lineage characterized by an original replication origin (i.e., *repA-oriV*) and included in the MOB~F11~ and MPF~T~ families, according to the typing schemes based on plasmid relaxases and on the MPF system, respectively ([@B25]; [@B41]). Interestingly, the MOB~F11~ family includes relaxases of plasmids belonging to IncW and IncN replicons, responsible for the spreading of antibiotic resistance determinants among enterobacteria, and to the IncP9 group, including metal-resistance and xenobiotic-biodegradation plasmids from *Pseudomonas* spp. ([@B20]; [@B50]). Based on replicase sequence homology, pMOS94-like plasmids showed a closer relatedness with the IncW replicon family. Further transfer experiments will be needed to evaluate the incompatibility behavior of these plasmids.

Sequence analyses revealed that members of this novel plasmid lineage were involved in spread of MBL-encoding genes, and accounted for a broad dissemination of such resistance determinants among pseudomonads of clinical and environmental origin, spanning over a time period of at least 20 years, among at least five different countries from two continents. However, the association of pMOS94 and pMOS94-like plasmids with resistance genes could be somewhat biased by the fact that the main purpose of bacterial sequencing focuses on antibiotic resistance.

The comparison of pMOS94-like plasmids highlighted a high phylogenetic relatedness within the lineage, which had likely evolved from a common ancestor. This point was also supported by the low sequence divergence observed among core backbone genes with the exception of pAER57, which was slightly more divergent. Nonetheless, the different insertion points of Tn*402*-like transposons and cognate integrons within the accessory region might represent a molecular marker of different evolutionary pathways for pMOS94 and pMOS94-like plasmids. In this scenario, different hypotheses could be made on the evolution of MGEs associated with this plasmid lineage: (i) the Tn*402*-like transposons could have been acquired following different insertion events that, in some cases (e.g., plasmids harboring blaVIM-1), occurred at the same site; (ii) at least three insertion events (occurring at different sites) led to the acquisition of the Tn*402*-like transposons, that subsequently evolved independently by genetic rearrangements and gene cassettes loss/acquisition. The number of the analyzed plasmids and sequence data publicly available for comparison, however, are limited and the chronological order of these events (i.e., the evolution of the backbone core genes and the acquisition of the accessory resistance regions) remains to be clarified.

Recently, a number of studies have described novel plasmid supports for different MBL genes among pseudomonads ([@B34]; [@B6]; [@B55]; [@B48]; [@B7], [@B8]; [@B43]; [@B35]), reporting on the structure of single plasmids or on structures circulating in a restricted geographical area or within a relatively short time period.

The present study contributed to extend current knowledge about the diversity and phylogeny of plasmids circulating in *Pseudomonas* spp., reporting on a successful plasmid lineage carrying MBL genes. Although mobilization experiments were not successful under the experimental conditions used in this study, the heterogeneous range of species carrying pMOS94-like plasmids suggests that these elements are able to be transferred. Therefore, further experiments are needed to evaluate their mobilization potential among GNNFs and eventually *Enterobacterales*, in order to better understand the possible contribution in disseminating antibiotic resistance traits by this novel plasmid lineage.

Nucleotide Sequence Accession Numbers
=====================================

The complete nucleotide sequence of pMOS94 from *P. mosselii* AM/94 and pAER57 from *P. aeruginosa* C/57 have been registered in GenBank under accession numbers [MK671725](MK671725) and [MK671726](MK671726), respectively.
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